Germany Respiratory Devices Market Insights Forecasts to 2033

• The Market is Growing at a CAGR of 5.1% from 2023 to 2033
• The Germany Respiratory Devices Market Size is Expected to Hold a Significant Share by 2033

The Germany Respiratory Devices Market Size is expected to hold a significant share by 2033, Growing at a CAGR of 5.1% from 2023 to 2033. The growing prevalence of respiratory disorders, the geriatric population, increasing R&D expenditure, and technological advancement are driving the growth of the respiratory devices market in Germany.     

Market Overview

Respiratory devices are used to help breathing that may be used by patients at home or in clinical settings, such as hospitals. These devices are intended to help patients, by supporting breathing, carbon dioxide removal, delivering a set amount of oxygen, and providing therapy to reduce the atrophy of abdominal wall muscles. It works by removing mucus from the airways and improves pulmonary functions. Some of the common respiratory devices are air cleaners, CPAP machines, BiPAP machines, portable emergency oxygen systems, nebulizers, pulse oximetry meters, home oxygen concentrators, portable oxygen cylinders, and suction machines. These devices seem to increase patients' compliance with daily treatment, with some beneficiary factors such as an independent application, full control of therapy, and easy use. Currently, respiratory devices are designed to enhance patient compliance and independence and are used to effectively improve pulmonary function, lung oxygenation, and clearing mucus from bronchi. The development of respiratory devices with smart technology integration, miniaturization and portability, and environmental sustainability will impact the market growth in the near future. The increasing product launches are estimated to enhance the market growth of respiratory devices.

Report Coverage

This research report categorizes the market for the Germany respiratory devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany Respiratory Devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany respiratory devices market.

Driving Factors

The rising prevalence of respiratory disorders, such as COPD, TB, asthma, lung cancer, and sleep apnea, technological advancement, and large patient population are expected to accelerate the market growth of respiratory devices. According to the Journal of Asthma and Allergy, asthma is reported to be one of the most common chronic disorders in Germany, affecting about 4-5% of adults and 10% of children each year. Thus, the increasing number of asthma patients in the country surges the demand for respiratory devices. Further, the growing geriatric population is also responsible for propelling the market demand for respiratory devices. Furthermore, the rising R&D expenditure and technological advancements in respiratory devices are expected to enhance the market growth. For instance, FAU (Germany) and McGill University Quebec (Canada) have received funding of USD 236.628 from the Free State Bavaria for designing wearable devices with automatic respiratory function monitoring systems.

Restraining Factors

Respiratory devices are expensive and are not affordable for low-income patients is likely to impede the market.

Market Segmentation

The Germany Respiratory Devices Market share is classified into Therapeutic Devices.

• The inhalers segment is expected to grow at the fastest CAGR during the forecast period.

Based on the therapeutic devices, the Germany respiratory devices market is categorized into CPAP devices, humidifiers, nebulizers, ventilators, oxygen concentrators, inhalers, and others. Among these, the inhalers segment is expected to grow at the fastest CAGR during the forecast period. Inhalers are used to treat or prevent respiratory diseases such as asthma, COPD, or cystic fibrosis. The medication is breathed through the mouth relaxes muscles, opens up the airways, and helps the patient breathe more easily. According to the study in the International Journal of COPD, single-inhaler triple therapy, which includes inhaled corticosteroid, beclomethasone, formoterol, and glycopyrronium is effective against COPD-specific symptoms and lung function parameters in COPD patients. Thus, effective inhalers for treating COPD diseases fueling the market in the inhalers segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany respiratory devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Geratherm Respiratory GmbH
• Fisher & Paykel Healthcare Ltd.
• GlaxoSmithKline PLC.
• DeVilbiss Healthcare GmbH
• Dragerwerk AG
• Invacare Corporation
• Koninklijke Philips NV
• Medtronic
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

·In October 2021, Movair, a respiratory therapy company, has announced the commercial launch of Luisa Life supporting Ventilator with high-flow oxygen therapy.

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Germany Respiratory Devices Market based on the below-mentioned segments:

Germany Respiratory Devices Market, By Therapeutic Devices

• CPAP Devices
• BiPAP Devices
• Humidifiers
• Nebulizers
• Ventilators
• Oxygen Concentrators
• Inhalers
• Others